C-UPKCRION
platelet-derived exosomes, PEP, drug delivery
repairingextracellular vesicle
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-UPKC
C-UPKCC-UPKCplatelet-derived exosomes, PEP, drug delivery
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Rion states that exosome therapeutics can activate the body’s innate ability to heal and represent a new generation of regenerative medicine. The company presents its platelet-derived Purified Exosome Product (PEP) as a pure, potent, practical, stable, and off-the-shelf biologic designed to make regenerative medicine more effective and accessible for patients globally, especially in areas where current standards of care are insufficient.
SourceRion states that exosome therapeutics can activate the body’s innate ability to heal and that regenerative medicine should be made practical, effective, and broadly accessible. The company presents its platelet-derived purified exosome product as a potent, stable, off-the-shelf biologic with potential to repair damaged tissues across multiple indications where existing standards of care are inadequate.
SourceRion states that exosome therapeutics can activate the body’s innate ability to heal and that its platelet-derived Purified Exosome Product (PEP) can serve as a potent, practical, room-temperature-stable, off-the-shelf regenerative medicine. The company presents accessibility and practicality as core beliefs, arguing that regenerative medicine should be effective and available to any patient anywhere, and that platelet exosomes can improve healing across damaged tissues where current standards of care are insufficient.
Source